ATE156362T1 - Antiherpes-zusammensetzungen - Google Patents

Antiherpes-zusammensetzungen

Info

Publication number
ATE156362T1
ATE156362T1 AT91122073T AT91122073T ATE156362T1 AT E156362 T1 ATE156362 T1 AT E156362T1 AT 91122073 T AT91122073 T AT 91122073T AT 91122073 T AT91122073 T AT 91122073T AT E156362 T1 ATE156362 T1 AT E156362T1
Authority
AT
Austria
Prior art keywords
antiherpes
compositions
combination
useful
disclosed
Prior art date
Application number
AT91122073T
Other languages
English (en)
Inventor
Robert Deziel
Yvan Guindon
Original Assignee
Boehringer Ingelheim Ca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ca Ltd filed Critical Boehringer Ingelheim Ca Ltd
Application granted granted Critical
Publication of ATE156362T1 publication Critical patent/ATE156362T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91122073T 1990-12-31 1991-12-21 Antiherpes-zusammensetzungen ATE156362T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002033448A CA2033448C (en) 1990-12-31 1990-12-31 Antiherpes compositions and method of use

Publications (1)

Publication Number Publication Date
ATE156362T1 true ATE156362T1 (de) 1997-08-15

Family

ID=4146737

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91122073T ATE156362T1 (de) 1990-12-31 1991-12-21 Antiherpes-zusammensetzungen

Country Status (9)

Country Link
US (1) US5552384A (de)
EP (1) EP0493770B1 (de)
JP (1) JP3209552B2 (de)
AT (1) ATE156362T1 (de)
AU (1) AU648855B2 (de)
CA (1) CA2033448C (de)
DE (1) DE69127184T2 (de)
IL (1) IL100549A (de)
NZ (1) NZ241121A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
SG65553A1 (en) * 1993-03-03 1999-06-22 Bio Mega Boehringer Ingelheim Inhibitors of herpes viral ribonucleotide reductase
CA2095408A1 (en) * 1993-05-03 1994-11-04 James Gus Chafouleas Method of combating acyclovir-resistant herpes simplex viral infections
US5459063A (en) * 1993-10-14 1995-10-17 The University Of Pennsylvania Plasmodium falciparum ribonucleotide reductase DNA
EP0948640A2 (de) * 1996-12-27 1999-10-13 Boehringer Ingelheim (Canada) Ltd. Verbesserte substrate für menschlichen cytomegalovirus
JP4110347B2 (ja) * 1999-11-05 2008-07-02 大鵬薬品工業株式会社 抗ｈｉｖ剤
US8853223B2 (en) 2010-09-17 2014-10-07 G2L Touch, Inc. Therapeutic composition to treat lesions caused by herpes simplex virus
WO2011035120A2 (en) * 2009-09-17 2011-03-24 Gk Ventures, L.L.C. Therapeutic composition to treat lesions caused by herpes simplex virus
JP2014141475A (ja) * 2012-12-27 2014-08-07 Daiichi Sankyo Co Ltd 新規美白剤
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor

Also Published As

Publication number Publication date
CA2033448C (en) 1996-11-26
AU9009391A (en) 1992-07-02
JP3209552B2 (ja) 2001-09-17
DE69127184T2 (de) 1997-12-18
NZ241121A (en) 1994-06-27
AU648855B2 (en) 1994-05-05
DE69127184D1 (de) 1997-09-11
EP0493770B1 (de) 1997-08-06
US5552384A (en) 1996-09-03
JPH04275229A (ja) 1992-09-30
EP0493770A3 (en) 1993-03-17
IL100549A (en) 1995-11-27
CA2033448A1 (en) 1992-07-01
EP0493770A2 (de) 1992-07-08
IL100549A0 (en) 1992-09-06

Similar Documents

Publication Publication Date Title
EP0481754A3 (en) Hydroxymethyl(methylenecyclopentyl)purines and pyrimidines
DK0513917T3 (da) Antivirale kombinationer indeholdende nukleosidanaloger
IL100550A0 (en) Synergistic pharmaceutical cosmetic compositions for treating herpes infections
DE69426904D1 (de) Phosphonat-Nukleotid Ester-Derivate
AU2219792A (en) Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
DE69127184D1 (de) Antiherpes-Zusammensetzungen
FI934366L (fi) Atp-analoger
BG102647A (en) Acyclic nucleoside derivatives
FI954615L (fi) Puriinien ja pyrimidiinien tyydyttämättömiä fosfonaattijohdannaisia
DK630589D0 (da) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning
ES2111569T3 (es) Inactivadores de enzimas.
ATE98249T1 (de) Phosphonoalkylpurin-derivate.
DE68901443D1 (de) Derivate von nukleosiden.
NZ239422A (en) Phospholipid derivatives of nucleosides and antiviral compositions
FI956246L (fi) Hiili-asykliset nukleosidijohdannaiset antiviraalisina ja antineoplastisina aineina
MX9102245A (es) Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes
ZA948907B (en) Use of 2-amino purine derivatives for the treatment and pro-phylaxis of human herpes virus 6 infections
IL102260A0 (en) Conjugates of antiviral nucleosides
MX9704336A (es) Uso de agentes antivirales para el tratamiento y profilaxis de infecciones latentes de herpesvirus.
IL106104A0 (en) Conjugates of antiviral nucleosides
KR920011939U (ko) 자동차의 후론트 사이드부재
ITBO920231V0 (it) Cercacambre ortopediche - cercametalli -

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties